Susan Sweeney

Susan Sweeney is a seasoned professional with a strong background in commercial leadership within the pharmaceutical industry, currently serving as the Senior Vice President Global Marketing, Access & Capabilities at Amgen.

With nearly 24 years of experience at Bristol-Myers Squibb, Susan has overseen the growth and development of key drugs across various therapeutic areas such as cardiovascular, diabetes, oncology, and infectious diseases.

She is known for her dedication to translating commercial insights into global product strategies and advocating for the application of real-world data in drug development to enhance customer experience, patient value, and access.

Susan is a passionate advocate for diversity and women empowerment in the workplace, actively participating in initiatives that promote health equity and mentoring other women in the industry.

She holds a Master's in Public Health, specializing in Epidemiology from Columbia University Mailman School of Public Health, and a Bachelor's in Business Administration and Management from Gettysburg College.

Recognized for her leadership, Susan was named one of Modern Healthcare's Top 25 Women Leaders in 2019 and listed among FiercePharma's Fiercest Women in Life Sciences in 2018.

Her extensive professional experience includes roles such as President and Head of US Commercial, SVP of World Wide Commercialization, CEO Chief of Staff at Bristol-Myers Squibb, among others.

Susan leverages her position to drive value for patients, healthcare systems, and team members, ensuring their contributions are valued and heard.

While closely associated with Amgen, she emphasizes that her opinions are personal and do not reflect the official position of the company.